Aprea therapeutics announces presentations at eortc-nci-aacr international conference on molecular targets and therapeutics

Doylestown, pa., oct. 10, 2024 (globe newswire) -- aprea therapeutics, inc. (nasdaq: apre) (“aprea”, or the “company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that four abstracts have been accepted for poster presentation at the eortc-nci-aacr symposium on molecular targets and cancer therapeutics, to take place in barcelona, spain, october 23 - 25, 2024. details on the posters are below.
NCI Ratings Summary
NCI Quant Ranking